Key considerations before the dust settles on a mega merger
This article was originally published in Scrip
Executive Summary
With companies carving off certain assets in their portfolios, both sellers and buyers are faced with the challenge of how to divest if they're selling, or integrate if they're buying that particular asset. With the ink only just dry on the deal, how well the company divests or integrates an asset can often make or break the success of the transaction, a factor the pharma sector understands more than most.